News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Onyx Pharmaceuticals, Inc. (ONXX) Set to Reap Big Gains


6/26/2012 10:21:10 AM

Shareholders of Onyx Pharmaceuticals Inc., are likely to see a gain of 40 percent more after the company received support from a regulatory panel for its cancer treatment carfilzomib, Bloomberg reports.

Analysts estimate that with the new treatment, Onyx's (NASDAQ: ONXX) revenue will more than double by 2014, with sales of carfilzomib reaching up to $1.5 billion a year.

Those numbers have helped Onyx become an attractive takeover target for major pharmaceutical companies.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES